Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - maraviroc - tablet, film coated - 150mg - maraviroc 150mg

Singapore - English - HSA (Health Sciences Authority)

glaxosmithkline pte ltd - maraviroc - tablet, film coated - 300mg - maraviroc 300mg

European Union - English - EMA (European Medicines Agency)

teva b.v.  - nevirapine - hiv infections - antivirals for systemic use - nevirapine teva is indicated in combination with other anti-retroviral medicinal products for the treatment of hiv 1 infected adults, adolescents, and children of any age.most of the experience with nevirapine is in combination with nucleoside reverse transcriptase inhibitors (nrtis). the choice of a subsequent therapy after nevirapine should be based on clinical experience and resistance testing.

European Union - English - EMA (European Medicines Agency)

roche registration ltd. - nelfinavir - hiv infections - antivirals for systemic use - viracept is indicated in antiretroviral combination treatment of human-immunodeficiency-virus (hiv-1)-infected adults, adolescents and children of three years of age and older.in protease-inhibitor (pi)-experienced patients, the choice of nelfinavir should be based on individual viral resistance testing and treatment history.

European Union - English - EMA (European Medicines Agency)

boehringer ingelheim international gmbh - nevirapine - hiv infections - antivirals for systemic use - tablets and oral suspensionviramune is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1-infected adults, adolescents, and children of any age.most of the experience with viramune is in combination with nucleoside reverse-transcriptase inhibitors (nrtis). the choice of a subsequent therapy after viramune should be based on clinical experience and resistance testing.50- and 100-mg prolonged-release tabletsviramune is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1-infected adolescents and children three years and above and able to swallow tablets.prolonged-release tablets are not suitable for the 14-day lead-in phase for patients starting nevirapine. other nevirapine formulations, such as immediate-release tablets or oral suspension should be used.most of the experience with viramune is in combination with nucleoside reverse-transcriptase inhibitors (nrtis). the choice of a subsequent therapy after viramune should be based on clinical experience and resistance testing.400-mg prolonged-release tabletsviramune is indicated in combination with other antiretroviral medicinal products for the treatment of hiv-1-infected adults, adolescents and children three years and above and able to swallow tablets.prolonged-release tablets are not suitable for the 14-day lead-in phase for patients starting nevirapine. other nevirapine formulations, such as immediate-release tablets or oral suspension should be used.most of the experience with viramune is in combination with nucleoside reverse-transcriptase inhibitors (nrtis). the choice of a subsequent therapy after viramune should be based on clinical experience and resistance testing.

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - nevirapine - tablet - 200 mg - nevirapine 200 mg

Singapore - English - HSA (Health Sciences Authority)

boehringer ingelheim singapore pte. ltd. - nevirapine anhydrous - tablet, extended release - 400 mg - nevirapine anhydrous 400 mg

Israel - English - Ministry of Health

j-c health care ltd - etravirine - tablets - etravirine 200 mg - etravirine - etravirine - intelence is indicated in combination with other antiretroviral medicinal products for the treatment of human immunodeficiency virus type 1 (hiv-1) infection in antiretroviral treatment-experienced adult patients including those with non-nucleoside reverse transcriptase inhibitor (nnrti) resistance. treatment history and when available resistance testing should guide the use of intelence. in patients who have experienced virological failure on an nnrti- and nucleoside or nucleotide reverse transcriptase inhibitor (n[t]rti)- containing regimen intelence is not recommended for use in combination with n(t)rtis only.

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - etravirine - tablet - 100mg - etravirine 100mg

Singapore - English - HSA (Health Sciences Authority)

johnson & johnson international (singapore) pte ltd - etravirine - tablet - 200mg/tablet - etravirine 200mg/tablet